GPCR - Structure Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

GPCR is currently covered by 10 analysts with an average price target of $107.35. This is a potential upside of $85.87 (399.77%) from yesterday's end of day stock price of $21.48.

Structure Therapeutics's activity chart (see below) currently has 79 price targets and 80 ratings on display. The stock rating distribution of GPCR is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 70.93% with an average time for these price targets to be met of 313.67 days.

Highest price target for GPCR is $145, Lowest price target is $70, average price target is $107.35.

Most recent stock forecast was given by JONATHAN WOLLEBEN from JMP on 09-Sep-2026. First documented stock forecast 28-Feb-2023.

Best performing analysts who are covering GPCR - Structure Therapeutics:

Jonathan Wolleben Andrew Fein Seamus Fernandez Yasmeen Rahimi Ananda Ghosh

Currently out of the existing stock ratings of GPCR, 21 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 19-Oct-2023

$110

$88.81 (419.11%)

$110

1 months 19 days ago
(09-Sep-2026)

10/15 (66.67%)

$68.77 (166.80%)

489

Buy Since 02-May-2025

$97

$75.81 (357.76%)

$100

2 months 21 days ago
(07-Aug-2026)

1/3 (33.33%)

$43.86 (82.54%)

220

Buy Since 20-Dec-2024

$70

$20.29 (40.82%)

$100

4 months 17 days ago
(11-Jun-2026)

3/6 (50%)

$26.7 (61.66%)

229

Buy Since 09-Apr-2024

$101

$79.81 (376.64%)

$101

4 months 21 days ago
(07-Jun-2026)

14/16 (87.5%)

$63.42 (168.76%)

433

Buy Since 28-Feb-2023

$145

$123.81 (584.29%)

$145

4 months 23 days ago
(05-Jun-2026)

4/10 (40%)

$107.42 (285.84%)

412

Show more analysts

Please expand the browser size to see the chart

What is GPCR (Structure Therapeutics) average time for price targets to be met?

On average it took 314 days for the stock forecasts to be reached, with an average price target met ratio of 70.93%.

Which analyst most recently updated their price target on GPCR (Structure Therapeutics)?

Jonathan Wolleben

Which analyst has the most public recommendations on GPCR (Structure Therapeutics)?

Jonathan Wolleben has 18 price targets and 14 ratings on GPCR

Which analyst is the currently most bullish on GPCR (Structure Therapeutics)?

Evan Seigerman with the highest potential upside of $123.81

Which analyst is the currently most reserved on GPCR (Structure Therapeutics)?

David Risinger with the lowest potential downside of $10.29
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?